Naturally oncolytic viruses

Area of Science:

• Virology
• Oncology
• Immunotherapy

Background:

• Naturally oncolytic viruses are replication-competent viruses with inherent tumor-targeting capabilities.
• Interest in naturally oncolytic viruses has historically been overshadowed by engineered viral vectors.
• Recent advancements have revitalized focus on their potency and selectivity in cancer treatment.

Purpose of the Study:

• To review the mechanisms by which naturally oncolytic viruses achieve tumor selectivity.
• To discuss the preclinical and clinical evidence supporting the use of naturally oncolytic viruses in cancer therapy.

Main Methods:

• Literature review of existing preclinical and clinical studies on naturally oncolytic viruses.
• Analysis of scientific data on viral mechanisms of tumor cell infection and lysis.

Main Results:

• Naturally oncolytic viruses demonstrate high selectivity for tumor cells, minimizing harm to healthy tissues.
• Preclinical studies show significant anti-tumor activity, with some naturally oncolytic viruses progressing to clinical trials.

Conclusions:

• Naturally oncolytic viruses represent a promising and potent therapeutic strategy for cancer treatment.
• Further research and clinical development are warranted to fully leverage their potential in oncology.